Impairment of spontaneous alternation performance by an NMDA antagonist: attenuation with non-NMDA treatments.
N-Methyl-D-aspartate (NMDA) receptor antagonists disrupt learning on a variety of tasks. Previous findings indicate that glucose, naloxone, and physostigmine ameliorate learning deficits produced by several treatments. The present experiment examines whether these agents also reverse the amnestic effects of NMDA receptor blockade. Mice were tested for spontaneous alternation performance in a Y-maze. The animals received either saline or the NMDA antagonist, NPC 12626 (35 mg/kg, IP), 50 min prior to testing and received an additional injection of saline, glucose, naloxone, or physostigmine 30 min prior to testing. NPC 12626 significantly decreased alternation scores. Glucose (250 mg/kg), physostigmine (0.01 mg/kg), and naloxone (1 mg/kg) reversed the effects of NPC 12626. Thus, impairments of learning after NMDA receptor blockade share with other amnestic conditions the susceptibility to attenuation by glucose, naloxone, and physostigmine.
Walker
D L
DL
Neuroscience Graduate Program, University of Virginia, Charlottesville 22903.
Gold
P E
PE
D000596:Amino Acids / Q000187:drug effects / Q000378:metabolism / Q000493:pharmacokinetics; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D007858:Learning / Q000187:drug effects*; D008297:Male; D008568:Memory / Q000187:drug effects; D051379:Mice; D016202:N-Methylaspartate; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors
D000596:Amino Acids; D016194:Receptors, N-Methyl-D-Aspartate; D016202:N-Methylaspartate